Category: Clinical studies

Positive progress for the immunosuppressant monitoring trial

Our Nanodem study to monitor immunosuppressant drugs that prevent rejection in transplant patients, is proceeding well. We now have 12 patients completed and will continue in the next 3 weeks with additional subjects.  In addition, Probe has been invited Munich to join a consortium involving Munich as well as other German, Austrian, Danish, Spanish and…
Read more »

Evaluations continue successfully

Review of first five patients at St Peter’s and continuation of the trial Following the start of the continuous, automatic glucose monitoring trial at St Peter’s Hospital Chertsey a review has been successfully carried out on the data received from the first five patients. The trial now continues with further patients. In addition to the…
Read more »

Successful start to immunosuppressant monitoring trial

  Wednesday 18th April saw the successful start to the Nanodem immunosuppressant monitoring trial in Munich. The first two patients completed their 48 hour monitoring and further patients are planned in the next few days. In addition to monitoring the immunosuppressant cyclosporine, it was also possible to monitor the patient’s glucose. Analysis of dialysate samples are…
Read more »

Advances in antibiotics therapy in the critically ill.

A recent paper by Jean Louis Vincent shows how important continuous therapeutic drug monitoring will be. Infections occur frequently in critically ill patients and their management can be challenging for various reasons, including delayed diagnosis, difficulties identifying causative microorganisms, and the high prevalence of antibiotic-resistant strains. In this review, we briefly discuss the importance of…
Read more »

Latest publication on Interstitial fluid for glucose control

Use of interstitial fluid in tight glycaemic control in ICU is not without risk.  Dr Mark O’Connell comments on a recent paper. Read full article The inherent weakness in all systems that rely on measuring interstitial fluid glucose (e.g. under the skin devices) is that they need clever algorithms to try to predict blood glucose. …
Read more »